Navigation Links
Preclinical study shows heroin vaccine blocks relapse
Date:5/6/2013

developed the vaccine three years ago.

Janda and his team therefore designed the heroin vaccine to elicit antibodies against not only heroin, but also 6-acetylmorphine and morphine. "The vaccine effectively tracks the drug as it is metabolized, keeping the active breakdown products out of the brain, and that, I think, explains its success," Janda said.

Rigorous Tests

Initial tests, reported in 2011, showed the vaccine could block some of the acute effects of heroin, such as obstructing pain. In the new study, the Koob laboratory put the vaccine through more rigorous tests.

"We gave the vaccine to rats that had already been exposed to heroin, a situation obviously relevant to a human clinical situation," said postdoctoral research associate Joel Schlosburg, who was first author of the study.

In one test, rats trained to press a lever three times to get an infusion of heroin later went through sessions of "extinction training," in which lever presses no longer produced infusions. Among rats that had not received the heroin vaccine, a single infusion of heroin could immediately reinstate a rat's drug-seeking lever-pressing behaviorjust as human users relapse to drug-seeking after re-exposure to heroin. However, rats that had been vaccinated failed to resume their heroin-seeking lever-presses.

In an even more challenging test, rats that had become severely addicted to heroin and were taking it compulsively in escalating amountsamounts that would have been lethal to drug-nave ratswere forced to abstain for 30 days before being given renewed access. In rats that had received a dummy vaccine, intake resumed and they re-escalated, taking the drug compulsively. But in the heroin-vaccinated rats, intake failed to escalate and compulsive drug taking did not redevelop.

"Basically we were able to stop them from going through that cycle of taking more and more heroin," said Schlosburg. "And that was with the
'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech, 2013 Edition
2. arGEN-X advances ARGX-113 into preclinical development for autoimmune disorders
3. Translating Preclinical Pharmacology to Clinical Activity with Myriad RBM’s Inflammation MAP
4. PROLOR Biotech To Present New Preclinical Data On Its Long-Acting Clotting Factor VIIa At Leading European Scientific Conference
5. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
6. Stemline Therapeutics, Inc. Announces Presentations of SL-401 Updated Clinical Trial Results in Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and SL-101 Preclinical Efficacy Data Against Hodgkins Lymphoma at
7. Inovio Pharmaceuticals Cytomegalovirus (CMV) Synthetic Vaccine Constructs Generate Strong and Broad T-Cell Responses in Preclinical Study
8. Karyopharm Therapeutics Announces Oral Presentation at the American College of Rheumatology (ACR) on the use of Selective Inhibitors of Nuclear Export (SINE) CRM1 Antagonists in preclinical models of Systemic Lupus Erythematosus (SLE)
9. Preclinical data shows 100 percent prevention and treatment of influenza with engineered human antibody
10. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
11. MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... 26, 2015  Platform therapeutic company Symic Biomedical, ... a $1.5M Phase II SBIR grant from the ... its therapeutic agent to reduce arteriovenous fistula (AVF) ... stage renal disease (ESRD) patients undergoing hemodialysis. The ... Diabetes and Digestive and Kidney Diseases (NIDDK), will ...
(Date:8/26/2015)... BEIJING , August 26, 2015 Israel ... DiaCardio wins 1 st place  Wayerz comes ... in Israel by venture capital fund JVP, ... including the US, China , Israel ... America .  Impressive achievement for the Israeli representatives ...
(Date:8/26/2015)... 26, 2015 After litigating and negotiating ... relating to P2i United States patent ... in the United States without any ... of either party. As a result of the parties, settlement, ... California dismissed the case without prejudice. ...
(Date:8/26/2015)... ... August 26, 2015 , ... PRC Clinical, a Clinical Trial ... with local sponsors in southern California. The Clinical Trial Management Expert CRO seeks to ... regulatory pathways., , Stem Cell Meeting on the Mesa ...
Breaking Biology Technology:Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6P2i Settles United States Litigation 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3
... Webcast to Be Held Today at 5:00 p.m. ET (22:00 CET), 2007 ... - Naglazyme net product revenue of $86.2 million, an increase of ... range of $82 million to $84 million, ... 28.5 percent over 2006 and toward the upper ...
... Recommend Pharmion ... with Celgene Special Meeting of ... Urges All Shareholders to Vote FOR the Proposed Merger, ... today announced that Institutional Shareholder Services,(ISS) has recommended that Pharmion ...
... in February issue of Clinical and Vaccine Immunology, ... and the University of Michigan have demonstrated their nasally,delivered ... lethal dose of smallpox, and without the safety risks ... smallpox virus,and builds immunity against it., The new ...
Cached Biology Technology:BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 2BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 3BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 4BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 5BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 6BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 7BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 8BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 9BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 10BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 11ISS Recommends Pharmion Shareholders Vote for Merger With Celgene 2ISS Recommends Pharmion Shareholders Vote for Merger With Celgene 3Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks 2Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks 3
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
(Date:8/12/2015)... Aug. 12, 2015  New research unveiled at ... Android phones to steal users, fingerprints. Information released ... of fingerprint scanners on mobile devices, making the ... secure biometrics on mobile devices, HYPR Corp. recently ... convenient authentication systems with strong cryptographic security. More ...
(Date:8/11/2015)... -- Today, ZUK announced its Android smartphone Z1, featuring ... revenues in 2015 that relate to sales of FPC1155 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... smartphone manufacturer in China and we ... 155 for Z1 , ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
... a trait which could be exploited in lands affected by ... the Society for Experimental Biology meeting on July 5, shows ... outer layer of their roots are more efficient at accessing ... Jonathan Lynch at the Pennsylvania State University, United States, found ...
... ITHACA, N.Y. With fewer than a dozen flowering plants ... caloric intake, people need to tap unused plants to feed ... geneticist Susan McCouch in the Comment feature of the July ... with population growth and rising incomes around the world, researchers ...
... TORONTO - A team of Toronto-based researchers may be one ... cells for use in research and therapy. Induced pluripotent ... research because they can flexibly develop into many different types ... proteins that control their generation are largely unknown. But ...
Cached Biology News:To feed the future, we must mine the wealth of the world's seed banks today 2Toronto team ID proteins key in stem cell production 2
... These handy dispensers save space ... wipers, hats, and other garb. ... storage bins for small parts ... manufacturing. Clear acrylic. Open-slot design ...
... is critical to the maintenance of ... proteins as important and diverse as ... shock and stress response, antigen presentation, ... ion channels, cell cycle regulation, transcription, ...
... The LIBS-ELITE houses Ocean Optics LIBS2000+ Spectrometers ... Universal Platform (UP) Ablation Chamber to offer ... control. The systems features include a high-power ... targeting functions, precise X-Y sample positioning, laser ...
... whole-blood clinical diagnostic work in hospitals and ... analyzer makes precise glucose measurements of whole ... measurements of whole blood, plasma, or cerebrospinal ... you to have glucose results expressed as ...
Biology Products: